These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12164075)

  • 1. A model for nurse-led skin cancer surveillance following renal transplantation.
    Reece SM; Harden PN; Smith AG; Ramsay HM
    Nephrol Nurs J; 2002 Jun; 29(3):257-9, 267. PubMed ID: 12164075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A population-based study of skin cancer incidence and prevalence in renal transplant recipients.
    Moloney FJ; Comber H; O'Lorcain P; O'Kelly P; Conlon PJ; Murphy GM
    Br J Dermatol; 2006 Mar; 154(3):498-504. PubMed ID: 16445782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and prediction of nonmelanoma skin cancer post-renal transplantation: a prospective study in Queensland, Australia.
    Carroll RP; Ramsay HM; Fryer AA; Hawley CM; Nicol DL; Harden PN
    Am J Kidney Dis; 2003 Mar; 41(3):676-83. PubMed ID: 12612993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of radiotherapy in the management of organ transplant recipients diagnosed with non-melanoma skin cancers.
    Veness MJ; Harris D
    Australas Radiol; 2007 Feb; 51(1):12-20. PubMed ID: 17217484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin surveillance of a U.K. paediatric transplant population.
    Thomson MA; Suggett NR; Nightingale PG; Milford DV; Baumann U; Kelly DA; Moss C; Hill VA
    Br J Dermatol; 2007 Jan; 156(1):45-50. PubMed ID: 17199565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting risk of nonmelanoma skin cancer and premalignant skin lesions in renal transplant recipients.
    Urwin HR; Jones PW; Harden PN; Ramsay HM; Hawley CM; Nicol DL; Fryer AA
    Transplantation; 2009 Jun; 87(11):1667-71. PubMed ID: 19502958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of proliferation signal inhibitors in non-melanoma skin cancer following renal transplantation.
    de Fijter JW
    Nephrol Dial Transplant; 2007 May; 22 Suppl 1():i23-6. PubMed ID: 17456615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-melanoma skin cancer and its risk factors in an Austrian population of heart transplant recipients receiving induction therapy.
    Geusau A; Dunkler D; Messeritsch E; Sandor N; Heidler G; Rödler S; Ankersmit J; Zuckermann A; Tschachler E
    Int J Dermatol; 2008 Sep; 47(9):918-25. PubMed ID: 18937654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melanomas in renal transplant recipients.
    Le Mire L; Hollowood K; Gray D; Bordea C; Wojnarowska F
    Br J Dermatol; 2006 Mar; 154(3):472-7. PubMed ID: 16445778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-melanoma skin cancer incidence and risk factors after kidney transplantation: a Canadian experience.
    Comeau S; Jensen L; Cockfield SM; Sapijaszko M; Gourishankar S
    Transplantation; 2008 Aug; 86(4):535-41. PubMed ID: 18724222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of immunosuppression for transplant-associated skin cancer: expert consensus survey.
    Otley CC; Berg D; Ulrich C; Stasko T; Murphy GM; Salasche SJ; Christenson LJ; Sengelmann R; Loss GE; Garces J;
    Br J Dermatol; 2006 Mar; 154(3):395-400. PubMed ID: 16445766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin cancer surveillance in renal transplant recipients: re-evaluation of U.K. practice and comparison with Australian experience.
    Garg S; Carroll RP; Walker RG; Ramsay HM; Harden PN
    Br J Dermatol; 2009 Jan; 160(1):177-9. PubMed ID: 18798841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Patients' knowledge of the risk of skin cancer following kidney transplantation].
    Cramer E; Rasmussen K; Jemec GB
    Ugeskr Laeger; 2009 Nov; 171(46):3341-5. PubMed ID: 19925738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excess risk of cancer in renal transplant patients.
    Kessler M; Jay N; Molle R; Guillemin F
    Transpl Int; 2006 Nov; 19(11):908-14. PubMed ID: 17018126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The historical link between solid-organ transplantation, immunosuppression, and skin cancer.
    Randle HW
    Dermatol Surg; 2004 Apr; 30(4 Pt 2):595-7. PubMed ID: 15061841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on the pathogenesis of post-transplant skin cancer in renal transplant recipients.
    Ho WL; Murphy GM
    Br J Dermatol; 2008 Feb; 158(2):217-24. PubMed ID: 18070205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subsequent skin cancers in kidney and heart transplant recipients after the first squamous cell carcinoma.
    Euvrard S; Kanitakis J; Decullier E; Butnaru AC; Lefrançois N; Boissonnat P; Sebbag L; Garnier JL; Pouteil-Noble C; Cahen R; Morelon E; Touraine JL; Claudy A; Chapuis F
    Transplantation; 2006 Apr; 81(8):1093-100. PubMed ID: 16641592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risk factors and development of skin neoplasms in patients after kidney transplantation].
    Sułowicz J; Krzanowski M; Wojas-Pelc A
    Przegl Lek; 2005; 62(7):698-702. PubMed ID: 16463705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of immunosuppression for transplant-associated skin cancer: thresholds and risks.
    Otley CC; Griffin MD; Charlton MR; Edwards BS; Neuburg M; Stasko T;
    Br J Dermatol; 2007 Dec; 157(6):1183-8. PubMed ID: 17916206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer incidence after immunosuppressive treatment following kidney transplantation.
    Andrés A
    Crit Rev Oncol Hematol; 2005 Oct; 56(1):71-85. PubMed ID: 15978827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.